These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 26655735)

  • 1. Protective immune barrier against hepatitis B is needed in individuals born before infant HBV vaccination program in China.
    Yang S; Yu C; Chen P; Deng M; Cao Q; Li Y; Ren J; Xu K; Yao J; Xie T; Wang C; Cui Y; Ding C; Tian G; Wang B; Zhang X; Ruan B; Li L
    Sci Rep; 2015 Dec; 5():18334. PubMed ID: 26655735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical characteristics of hepatitis B virus infection in middle school students born after the universal infant vaccination program in Shanghai, China.
    Wang WL; Shu ZJ; Zhou LX; Zhao YR
    Arch Virol; 2012 May; 157(5):901-5. PubMed ID: 22327392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serological and molecular epidemiological outcomes after two decades of universal infant hepatitis B virus (HBV) vaccination in Nunavut, Canada.
    Huynh C; Minuk GY; Uhanova J; Baikie M; Wong T; Osiowy C
    Vaccine; 2017 Aug; 35(35 Pt B):4515-4522. PubMed ID: 28736196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV viraemia during hepatitis B vaccination shortens the duration of protective antibody levels.
    O'Bryan TA; Rini EA; Okulicz J; Messner O; Ganesan A; Lalani T; Bavaro MF; O'Connell RJ; Agan BK; Landrum ML
    HIV Med; 2015 Mar; 16(3):161-7. PubMed ID: 25586899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-term efficacy of infant hepatitis B immunization program].
    Gong J; Li RC; Yang JY; Li YP; Chen XR; Xu ZY; Liu CB; Cao HL; Zhao K; Ni DM
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):203-5. PubMed ID: 12716514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preliminary analysis on the prevalence and causes of breakthrough hepatitis B virus infection among children in Shandong province, China].
    Zhang L; Yan BY; Li MS; Song LZ; Lü JJ; Xu Q; Xu AQ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2013 Oct; 47(10):933-9. PubMed ID: 24378135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Key outcomes and addressing remaining challenges--perspectives from a final evaluation of the China GAVI project.
    Yang W; Liang X; Cui F; Li L; Hadler SC; Hutin YJ; Kane M; Wang Y
    Vaccine; 2013 Dec; 31 Suppl 9():J73-8. PubMed ID: 24331024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent and transient hepatitis B virus (HBV) infections in children born to HBV-infected mothers despite active and passive vaccination.
    Boot HJ; Hahné S; Cremer J; Wong A; Boland G; van Loon AM
    J Viral Hepat; 2010 Dec; 17(12):872-8. PubMed ID: 20051008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody titration and immune response of Iranian beta-thalassemic patients to hepatitis B virus vaccine (booster effect).
    Azarkeivan A; Karimi G; Shaiegan M; Maghsudlu M; Tabbaroki A
    Pediatr Hematol Oncol; 2009 Jun; 26(4):195-201. PubMed ID: 19437322
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased seroprevalence of HBV DNA with mutations in the s gene among individuals greater than 18 years old after complete vaccination.
    Lai MW; Lin TY; Tsao KC; Huang CG; Hsiao MJ; Liang KH; Yeh CT
    Gastroenterology; 2012 Aug; 143(2):400-7. PubMed ID: 22580098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of the nationwide hepatitis B infant vaccination program in Taiwan.
    Chen SM; Kung CM; Yang WJ; Wang HL
    J Clin Virol; 2011 Sep; 52(1):11-6. PubMed ID: 21767983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroepidemiology of hepatitis B virus infection and impact of vaccination.
    Huang P; Zhu LG; Zhu YF; Yue M; Su J; Zhu FC; Yang HT; Zhang Y; Shen HB; Yu RB; Zhai XJ; Peng ZH
    World J Gastroenterol; 2015 Jul; 21(25):7842-50. PubMed ID: 26167084
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt.
    Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN
    Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Serum Anti-HBs Level Among Children Who Received Routine Hepatitis B Vaccination During Infancy in Mianyang City, China: A Cross-Sectional Study.
    He F; Ma YJ; Zhou TY; Duan JC; Wang JF; Ji YL; Li H; Zhang JY; Tang H
    Viral Immunol; 2016; 29(1):40-8. PubMed ID: 26565951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of hepatitis B vaccination among children in Guangdong Province, China.
    Xiao J; Zhang J; Wu C; Shao X; Peng G; Peng Z; Ma W; Zhang Y; Zheng H
    Int J Infect Dis; 2012 Sep; 16(9):e692-6. PubMed ID: 22795176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Seroepidemiological study of hepatitis B virus markers in Japan.
    Kiyohara T; Ishii K; Mizokami M; Sugiyama M; Wakita T
    Vaccine; 2015 Nov; 33(45):6037-42. PubMed ID: 26341564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prevalence of HBV Infection: A Retrospective Study of 13 Years in a Public Hospital of Northeast China.
    Jin Y; Geng N; Zhao L; Li Y; Zheng L; Zhu W; Sheng Q; An Z; Wang J; Dou X; Bai H
    Viral Immunol; 2020 Mar; 33(2):99-104. PubMed ID: 31834847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological serosurvey of hepatitis B virus among children aged 1-14 years in Guangdong Province, China.
    Zhu Q; Shao X; Chen S; Li D; Chen X; Liu W; Wu X; Jian Z; Rutherford S; Zheng H
    Int J Infect Dis; 2018 Jun; 71():25-29. PubMed ID: 29408358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of hepatitis B surface antigen (HBsAg) in a blood donor population born prior to and after implementation of universal HBV vaccination in Shenzhen, China.
    Wang Z; Zeng J; Li T; Zheng X; Xu X; Ye X; Lu L; Zhu W; Yang B; Allain JP; Li C
    BMC Infect Dis; 2016 Sep; 16():498. PubMed ID: 27647214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Primary prevention by hepatitis B vaccine on liver cancer in high incidence area of China].
    Wang YT; Chen TY; Zhu J; Jiao YC; Qu CF
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Apr; 52(4):402-408. PubMed ID: 29614608
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.